Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Acuren Sees FY2025 Sales $1.530B-$1.565B vs $1.139B Est

Author: Benzinga Newsdesk | September 30, 2025 08:23am
Acuren (NYSE:TIC) sees FY2025 sales of $1.530 billion-$1.565 billion vs $1.139 billion analyst estimate.

Posted In: TIC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist